Dietary Fructose and Fructose-Induced Pathologies-Reference-Cited by-同舟云学术

Dietary Fructose and Fructose-Induced Pathologies

Published:2022-08-22 Issue:1 Volume:42 Page:45-66
ISSN:0199-9885
Container-title:Annual Review of Nutrition
language:en
Short-container-title:Annu. Rev. Nutr.

Author:

Jung Sunhee¹,Bae Hosung¹,Song Won-Suk¹²,Jang Cholsoon¹³⁴⁵

Affiliation:

1. Department of Biological Chemistry, University of California, Irvine, California, USA;, , ,

2. Institute of Bioengineering, Bio-MAX, Seoul National University, Seoul, South Korea

3. Chao Family Comprehensive Cancer Center, University of California, Irvine, California, USA

4. Center for Complex Biological Systems, University of California, Irvine, California, USA

5. Center for Epigenetics and Metabolism, University of California, Irvine, California, USA

Abstract

The consumption of fructose as sugar and high-fructose corn syrup has markedly increased during the past several decades. This trend coincides with the exponential rise of metabolic diseases, including obesity, nonalcoholic fatty liver disease, cardiovascular disease, and diabetes. While the biochemical pathways of fructose metabolism were elucidated in the early 1990s, organismal-level fructose metabolism and its whole-body pathophysiological impacts have been only recently investigated. In this review, we discuss the history of fructose consumption, biochemical and molecular pathways involved in fructose metabolism in different organs and gut microbiota, the role of fructose in the pathogenesis of metabolic diseases, and the remaining questions to treat such diseases.

Publisher

Annual Reviews

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

https://www.annualreviews.org/doi/pdf/10.1146/annurev-nutr-062220-025831

Reference149 articles.

1. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

2. Host Genetic Background and Gut Microbiota Contribute to Differential Metabolic Responses to Fructose Consumption in Mice

3. Umami-induced obesity and metabolic syndrome is mediated by nucleotide degradation and uric acid generation

4. Protective role of fructokinase blockade in the pathogenesis of acute kidney injury in mice

5. Slc2a5 (Glut5) Is Essential for the Absorption of Fructose in the Intestine and Generation of Fructose-induced Hypertension

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of BI-9787, a potent zwitterionic ketohexokinase inhibitor with oral bioavailability;Bioorganic & Medicinal Chemistry Letters;2024-11

2. Protective role of cells and spores of Shouchella clausii SF174 against fructose-induced gut dysfunctions in small and large intestine;The Journal of Nutritional Biochemistry;2024-11

3. Interindividual Variability in Postprandial Plasma Fructose Patterns in Adults;Nutrients;2024-09-13

4. Long-term high fructose intake reprograms the circadian transcriptome and disrupts homeostasis in mouse extra-orbital lacrimal glands;Experimental Eye Research;2024-09

5. Comparative effects of viable Lactobacillus rhamnosus GG and its heat‐inactivated paraprobiotic in the prevention of high‐fat high‐fructose diet‐induced non‐alcoholic fatty liver disease in rats;BioFactors;2024-08-12